Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1Phase 1 1

Status

Completed 60Unknown 11Withdrawn 4Terminated 4Recruiting 3Active not recruiting 3Not yet recruiting 1

Sponsor Class

OTHER 3NETWORK 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2Other hematologic neoplasm 1Head & Neck 1Breast 1

Conditions

Breast Neoplasms 370Neoplasms 253Carcinoma, Non-Small-Cell Lung 224Prostatic Neoplasms 192Lung Neoplasms 142Colorectal Neoplasms 139Neoplasm Metastasis 132Pancreatic Neoplasms 131Leukemia, Myeloid, Acute 126Multiple Myeloma 123Lymphoma 115Carcinoma, Hepatocellular 111Ovarian Neoplasms 98Melanoma 97Recurrence 93Leukemia 89Head and Neck Neoplasms 89Leukemia, Lymphocytic, Chronic, B-Cell 86Brain Neoplasms 86Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Glioblastoma 77Lymphoma, Non-Hodgkin 73Squamous Cell Carcinoma of Head and Neck 71Lymphoma, Follicular 70Lymphoma, Large B-Cell, Diffuse 66Colonic Neoplasms 66Carcinoma, Renal Cell 62Hematologic Neoplasms 59Sarcoma 55Glioma 53

Interventions

parathyroid hormone-related peptide (1-36) 1Zoledronic Acid 1Risedronic Acid 1Parathyroid Hormone-Related Protein 1Parathyroid Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Withdrawn × Interventional × Osteoporosis × Clear all
NCT02632903 2018-08-22

Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study

Children's Hospital of Eastern Ontario

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

Osteonecrosis, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01841814 2016-12-05

LYMPHOS

Centre Hospitalier Universitaire, Amiens

Phase 4 Withdrawn
Lymphoid

Lymphoma, Osteoporosis

NCT01333267 2014-12-05

One Week Comparison Study of PTH and PTHrP Infusions

University of Pittsburgh

Phase 1 Withdrawn
Head & Neck

Humoral Hypercalcemia Of Malignancy, Bone Diseases, Endocrine, Endocrine System Diseases, Hyperparathyroidism, Musculoskeletal Diseases, Osteoporosis

NCT00324714 2012-11-29

Risedronate in Improving Bone Mineral Density and Bone Health in Postmenopausal Women With Ductal Carcinoma In Situ Enrolled in Clinical Trial CRUK-IBIS-II-DCIS

ETOP IBCSG Partners Foundation

Phase 3 Withdrawn
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Osteoporosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡